Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records

— News, features, and commentary about cancer-related issues

MedicalToday
Onco Break over a computer rendering of a cancer cell.

Possibly uncovering a clue to a longstanding mystery, Italian researchers found that aspirin may help prevent colorectal cancer by . (Cancer)

The FDA for lutetium Lu 177 dotatate (Lutathera) to include pediatric patients with gastroenteropancreatic neuroendocrine tumors, Novartis announced.

Gilead Sciences will , an anti-CD47 antibody, for hematologic malignancies. (BioSpace)

Amid slumping sales and stock prices, Roche will . (Bloomberg)

Innate Pharma and 23andMe have joined forces to develop anticancer antibodies that . (BioSpace)

The American Society of Clinical Oncology and the College of American Pathologists have called on manufacturers of diagnostic and therapeutic products to adopt to improve access to effective therapies.

The University of Texas MD Anderson Cancer Center will to Chicago in a partnership with RUSH University Health System.

St. Jude Children's Research Hospital named Andrew Smith, MD, PhD, an authority on , as head of diagnostic imaging.

Integrating may help relieve physician burden and improve patient education but still requires a "physician in the loop" as a backstop for errors in messaging. (Mass General Brigham, The Lancet Digital Health)

The has increased across all racial and ethnic groups, although mortality remains higher among African Americans. (Blood Advances)

Contradicting conventional wisdom, a study suggests that normalizing tumor blood vessels and improving oxygen levels may in preventing lung cancer progression. (Phoenix Children's Hospital, EMBO Molecular Medicine)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined in 2007.